ResMed chairman and CEO Michael J. Farrell reports sale of common shares worth $1.18 million
RMD•Michael J. Farrell sold 4,993 ResMed common shares for $235.3473 per share on Nov. 9, 2026, and exercised options for the same number of shares at $146.34 each.
1. Share transactions
Farrell sold 4,993 common shares at $235.3473 per share and exercised options for 4,993 common shares at $146.34 per share on Nov. 9, 2026. After the transactions, he directly owned 479,803 common shares, with another 2,090 held indirectly through the Lisette and Michael Farrell Family Trust.
